Protein & macro calculator with GLP-1 muscle-preservation overlay

GLP-1 Protein & Macro Calculator

Calculate your daily protein target, BMR, TDEE, and macro split. The calculator bumps the protein target one tier higher when you flag “on a GLP-1” because the published STEP-1 and SURMOUNT-1 body composition substudies show 25-45% of weight loss is lean tissue without protein and resistance training intervention.

Your daily targets

BMR
1563 kcal
TDEE
2150 kcal
Target calories
1650 kcal
Weekly change
-0.45 kg/wk
Daily protein target
171 g
(152-191 g range)
Tier: High-deficit / trained / GLP-1 patient (1.6-2.0 g/kg)GLP-1 BUMP APPLIED
Per meal (×3): ~57 g — even distribution across breakfast, lunch, and dinner maximizes 24-hour muscle protein synthesis (Mamerow 2014).
Protein
171 g
Fat
46 g
Carbs
138 g

How the calculator works

The math is simple but every coefficient is sourced from a peer-reviewed primary source.

  • BMR (Mifflin-St Jeor 1990, PMID 2305711) [1]:
    Male: 10×W(kg) + 6.25×H(cm) − 5×age + 5
    Female: 10×W(kg) + 6.25×H(cm) − 5×age − 161
  • TDEE (FAO/WHO/UNU 2001 PAL multipliers) [13]: BMR × {1.2, 1.375, 1.55, 1.725, 1.9} for sedentary, light, moderate, very, and extremely active.
  • Caloric deficit (Hall 2011, PMID 21872751) [10]: 500 kcal/day deficit for weight loss yields ~0.45 kg/week at steady state. Real rates are slower due to metabolic adaptation.
  • Protein tier selection (see below).
  • Per-meal split (Mamerow 2014, PMID 24477298) [5]: even distribution across 3 main meals increased 24-h muscle protein synthesis by ~25% versus skewed.

The protein tier ladder

Five tiers, each anchored on a specific published recommendation:

  • 0.8 g/kg/day — the RDA. Sufficient for sedentary adults at maintenance, almost certainly insufficient for anyone losing weight on a GLP-1.
  • 1.0-1.2 g/kg/day — PROT-AGE 2013 [2] recommendation for healthy older adults at maintenance.
  • 1.2-1.6 g/kg/day — PROT-AGE for disease/exercise, ESPEN 2014 [8] for older adults with disease, and the lower end of the ISSN 2017 [4] range for active individuals.
  • 1.6-2.0 g/kg/day — ISSN 2017 [4] recommendation for active individuals, and the Neeland 2024 [9] target for GLP-1 patients.
  • 2.0-2.4 g/kg/day — Longland 2016 [3] high arm (added LBM during a 4-week severe deficit + RT), Mettler 2010 [7] LBM preservation in trained athletes during weight loss, and Helms 2014 [6] contest-prep range.

The GLP-1 bump

Patients flagging that they are on (or starting) a GLP-1 receptor agonist get bumped one tier higher than they would otherwise. The reason: the STEP-1 [11] and SURMOUNT-1 [12] body composition substudies show 25-45% of total weight loss on these drugs is lean tissue without protein and resistance training intervention, and the Neeland 2024 [9] review on GLP-1 lean mass mitigation specifically recommends targeting the higher end of the protein range (1.6-2.3 g/kg fat-free mass) for this population. The bump is the clinical translation of that finding.

What this calculator does NOT do

  • It does not measure your body fat or lean mass. The protein target is based on total body weight, not fat-free mass. DXA-based fat-free-mass targeting is more precise and is what clinical trials use; for home use, total body weight is an acceptable proxy.
  • It does not adjust for kidney disease. Patients with chronic kidney disease (eGFR < 60) should discuss protein intake with their nephrologist before pushing into the higher tiers.
  • It does not provide a meal plan. It tells you targets; you and a registered dietitian can build the plan.
  • It does not replace a clinical conversation with your prescriber, especially if you are managing diabetes, kidney disease, or any condition that affects nutrition.

Important disclaimer

This calculator is for educational purposes only and does not constitute medical advice or dietary prescription. The published protein recommendations are from healthy adult and older-adult populations and do not directly apply to patients with chronic kidney disease, advanced liver disease, or metabolic disorders. Patients with any of these conditions should consult a registered dietitian or their prescribing clinician before adopting the targets in this tool. Every coefficient was verified against PubMed primary sources by a research subagent on 2026-04-07.

Related tools and research

References

  1. 1.Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990. PMID: 2305711.
  2. 2.Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013. PMID: 23867520.
  3. 3.Longland TM, Oikawa SY, Mitchell CJ, Devries MC, Phillips SM. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. Am J Clin Nutr. 2016. PMID: 26817506.
  4. 4.Jäger R, Kerksick CM, Campbell BI, Cribb PJ, Wells SD, Skwiat TM, Purpura M, Ziegenfuss TN, Ferrando AA, Arent SM, Smith-Ryan AE, Stout JR, Arciero PJ, Ormsbee MJ, Taylor LW, Wilborn CD, Kalman DS, Kreider RB, Willoughby DS, Hoffman JR, Krzykowski JL, Antonio J. International Society of Sports Nutrition Position Stand: protein and exercise. J Int Soc Sports Nutr. 2017. PMID: 28642676.
  5. 5.Mamerow MM, Mettler JA, English KL, Casperson SL, Arentson-Lantz E, Sheffield-Moore M, Layman DK, Paddon-Jones D. Dietary protein distribution positively influences 24-h muscle protein synthesis in healthy adults. J Nutr. 2014. PMID: 24477298.
  6. 6.Helms ER, Aragon AA, Fitschen PJ. Evidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementation. J Int Soc Sports Nutr. 2014. PMID: 24864135.
  7. 7.Mettler S, Mitchell N, Tipton KD. Increased protein intake reduces lean body mass loss during weight loss in athletes. Med Sci Sports Exerc. 2010. PMID: 19927027.
  8. 8.Deutz NEP, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014. PMID: 24814383.
  9. 9.Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024. PMID: 38937282.
  10. 10.Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011. PMID: 21872751.
  11. 11.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PMID: 33567185.
  12. 12.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. PMID: 35658024.
  13. 13.Food and Agriculture Organization / World Health Organization / United Nations University. Human Energy Requirements: Report of a Joint FAO/WHO/UNU Expert Consultation. Rome, October 17-24, 2001 — Physical Activity Level (PAL) multipliers. FAO Food and Nutrition Technical Report Series. 2004. https://www.fao.org/3/y5686e/y5686e00.htm